JPMorgan Chase & Co’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-128
| Closed | -$453 | – | 6435 |
|
|
2025
Q1 | $453 | Buy |
+128
| New | +$453 | ﹤0.01% | 5836 |
|
|
2024
Q1 | – | Sell |
-13
| Closed | -$56 | – | 6550 |
|
|
2023
Q4 | $56 | Buy |
13
+4
| +44% | +$17 | ﹤0.01% | 6149 |
|
|
2023
Q3 | $31 | Buy |
+9
| New | +$31 | ﹤0.01% | 6127 |
|
|
2022
Q4 | – | Sell |
-1,787
| Closed | -$9K | – | 5781 |
|
|
2022
Q3 | $9K | Sell |
1,787
-1,959
| -52% | -$9.87K | ﹤0.01% | 5089 |
|
|
2022
Q2 | $21K | Sell |
3,746
-4,272
| -53% | -$23.9K | ﹤0.01% | 5054 |
|
|
2022
Q1 | $57K | Buy |
8,018
+2,768
| +53% | +$19.7K | ﹤0.01% | 4972 |
|
|
2021
Q4 | $42K | Buy |
+5,250
| New | +$42K | ﹤0.01% | 5131 |
|